9 research outputs found
Therapeutic intervention with anti-complement component 5 antibody does not reduce nash but does attenuate atherosclerosis and mif concentrations in ldlr-/-.Leiden mice
Background: Chronic inflammation is an important driver in the progression of nonalcoholic steatohepatitis (NASH) and atherosclerosis. The complement system, one of the first lines of
defense in innate immunity, has been implicated in both diseases. However, the potential therapeutic
value of complement inhibition in the ongoing disease remains unclear. Methods: After 20 weeks of
high-fat diet (HFD) feeding, obese Ldlr-/-.Leiden mice were treated twice a week with an established
anti-C5 antibody (BB5.1) or vehicle control. A separate group of mice was kept on a chow diet
as a healthy reference. After 12 weeks of treatment, NASH was analyzed histopathologically, and
genome-wide hepatic gene expression was analyzed by next-generation sequencing and pathway
analysis. Atherosclerotic lesion area and severity were quantified histopathologically in the aortic
roots. Results: Anti-C5 treatment considerably reduced complement system activity in plasma and
MAC deposition in the liver but did not affect NASH. Anti-C5 did, however, reduce the development
of atherosclerosis, limiting the total lesion size and severity independently of an effect on plasma
cholesterol but with reductions in oxidized LDL (oxLDL) and macrophage migration inhibitory
factor (MIF). Conclusion: We show, for the first time, that treatment with an anti-C5 antibody in
advanced stages of NASH is not sufficient to reduce the disease, while therapeutic intervention
against established atherosclerosis is beneficial to limit further progression
Intra-Firm Wage Dispersion and Firm Performance: Evidence from Linked Employer-Employee Data
Cet article analyse la relation entre la dispersion salariale intra-firme et la performance au sein de grandes entreprises belges à partir de données appareillées employeur-employé. Sur base de la méthodologie de Winter-Ebmer et Zweimüller (1999), nous trouvons une relation positive et significative entre la dispersion salariale au sein des entreprises et les profits par tête. Ce résultat est obtenu en contrôlant pour les caractéristiques des travailleurs et des entreprises ainsi qu'en abordant le problème potentiel de la simultanéité. Nos estimations indiquent également que l'intensité de la relation est plus forte pour les ouvriers ainsi qu'au sein des entreprises avec un degréélevé de monitoring. Ces résultats correspondent davantage à la théorie des 'tournois' qu'aux modèles de 'coopération'. Copyright WWZ and Helbing & Lichtenhahn Verlag AG 2004.
The complement system drives local inflammatory tissue priming by metabolic reprogramming of articular fibroblasts
Arthritis typically involves recurrence and progressive worsening at specific predilection sites, but the checkpoints between remission and persistence remain unknown. Here, we defined the molecular and cellular mechanisms of this inflammation-mediated tissue priming. Re-exposure to inflammatory stimuli caused aggravated arthritis in rodent models. Tissue priming developed locally and independently of adaptive immunity. Repeatedly stimulated primed synovial fibroblasts (SFs) exhibited enhanced metabolic activity inducing functional changes with intensified migration, invasiveness and osteoclastogenesis. Meanwhile, human SF from patients with established arthritis displayed a similar primed phenotype. Transcriptomic and epigenomic analyses as well as genetic and pharmacological targeting demonstrated that inflammatory tissue priming relies on intracellular complement C3- and C3a receptor-activation and downstream mammalian target of rapamycin- and hypoxia-inducible factor 1α-mediated metabolic SF invigoration that prevents activation-induced senescence, enhances NLRP3 inflammasome activity, and in consequence sensitizes tissue for inflammation. Our study suggests possibilities for therapeutic intervention abrogating tissue priming without immunosuppression
The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts.
Arthritis typically involves recurrence and progressive worsening at specific predilection sites, but the checkpoints between remission and persistence remain unknown. Here, we defined the molecular and cellular mechanisms of this inflammation-mediated tissue priming. Re-exposure to inflammatory stimuli caused aggravated arthritis in rodent models. Tissue priming developed locally and independently of adaptive immunity. Repeatedly stimulated primed synovial fibroblasts (SFs) exhibited enhanced metabolic activity inducing functional changes with intensified migration, invasiveness and osteoclastogenesis. Meanwhile, human SF from patients with established arthritis displayed a similar primed phenotype. Transcriptomic and epigenomic analyses as well as genetic and pharmacological targeting demonstrated that inflammatory tissue priming relies on intracellular complement C3- and C3a receptor-activation and downstream mammalian target of rapamycin- and hypoxia-inducible factor 1α-mediated metabolic SF invigoration that prevents activation-induced senescence, enhances NLRP3 inflammasome activity, and in consequence sensitizes tissue for inflammation. Our study suggests possibilities for therapeutic intervention abrogating tissue priming without immunosuppression
The politics of culture in Northern Ireland
OBJECTIVES: The first consensus report that had been presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, The Netherlands. METHODS: Medical oncologists, urologic surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference and incorporated the new data into updated and revised guidelines. As for the first meeting the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. RESULTS: The second part of the consensus paper includes the treatment of metastasised disease, residual tumour resection, salvage therapy, follow-up, and late toxicities. CONCLUSIONS: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early-stage as well as of advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. In addition, the particular needs of testicular cancer survivors have been acknowledged
GNU Radio
GNU Radio is a free & open-source software development toolkit that provides signal processing blocks to implement software radios. It can be used with readily-available, low-cost external RF hardware to create software-defined radios, or without hardware in a simulation-like environment. It is widely used in hobbyist, academic, and commercial environments to support both wireless communications research and real-world radio systems